Admission Levels of Serum P-Selectin and IL-6 Can Predict Development of Deep Venous Thrombosis in Hospitalized

Nehal Farouk1, Walaa Mohamed Omar Ashry2, Hanan A El-Hagrasy3

  • 1Vascular Surgery Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.

Insights

Elevated levels of Interleukin-6 (IL-6) and P-selectin are linked to deep venous thrombosis (DVT) in hospitalized COVID-19 patients. These markers may play a role in DVT development during infection.

Area of Science:

  • Medical Research
  • Infectious Diseases
  • Hematology

Background:

  • Deep venous thrombosis (DVT) is a frequent complication in COVID-19 patients.
  • Elevated levels of Interleukin-6 (IL-6) and P-selectin have been observed in COVID-19.
  • The relationship between these markers and DVT in COVID-19 requires further investigation.

Purpose of the Study:

  • To evaluate P-selectin and IL-6 levels in COVID-19 patients with DVT.
  • To explore the association between these inflammatory markers and clinical/laboratory parameters in COVID-19 patients with DVT.

Main Methods:

  • Retrospective study of 150 hospitalized COVID-19 patients.
  • Measurement of IL-6 and P-selectin using enzyme-linked immunosorbent assay.
  • Diagnosis of DVT via Doppler ultrasound of the lower extremities.

Main Results:

  • DVT developed in 39.3% of patients.
  • Patients with DVT exhibited significantly higher P-selectin and IL-6 levels (p < 0.001).
  • P-selectin and IL-6 demonstrated good performance in identifying DVT (AUCs 0.72-0.86).
  • Severe disease, elevated P-selectin, and elevated IL-6 were significant predictors of DVT.

Conclusions:

  • Elevated P-selectin and IL-6 levels are likely involved in DVT development in hospitalized COVID-19 patients.
  • These markers may serve as potential indicators for DVT risk in this population.
Abstract

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
31
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
22
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
42
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
45